{"id":"W4220735712","doi":"10.1016/j.cjco.2022.03.003","title":"Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study","year":2022,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cardiome (Canada); Université Laval; Centre hospitalier universitaire de Québec; Amgen (Canada); Cambridge Cardiac Care Centre; Island Health; University of British Columbia; McMaster University","funders":"Amgen Canada; Sanofi; Kowa Company; Amgen; Boehringer Ingelheim; Novo Nordisk; Bayer; AstraZeneca; Regeneron Pharmaceuticals; Novartis; HLS Therapeutics; Pfizer","keywords":"Evolocumab; Medicine; PCSK9; Internal medicine; Statin; Alirocumab; Adverse effect; Hyperlipidemia; Apolipoprotein B; Gastroenterology; Cholesterol; Lipoprotein; Endocrinology; Diabetes mellitus; Apolipoprotein A1","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008119181,0.0001539822,0.000685942,0.000309069,0.0004165384,0.00008587159,0.0004889866,0.00003475515,0.0003746706],"category_scores_gemma":[0.00007167525,0.00009683298,0.0001183019,0.001871131,0.00002951304,0.0001664783,0.0003516418,0.0004504664,0.00001251402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008578452,"about_ca_system_score_gemma":0.0007789684,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9692779,"about_ca_topic_score_gemma":0.9694494,"domain_scores_codex":[0.997767,0.0005145387,0.0003052944,0.0004538748,0.0006755037,0.0002837378],"domain_scores_gemma":[0.9981109,0.00007942481,0.00007921411,0.001378482,0.0000887875,0.000263148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002459072,0.0002668741,0.9921846,0.000003125165,0.001203284,0.00009674783,0.002634492,0.0001351688,3.760268e-7,0.00003202248,0.0009371875,0.002260203],"study_design_scores_gemma":[0.003724812,0.0004298636,0.9730831,0.00001448522,0.000815642,5.096198e-7,0.00198333,0.00005899368,0.000001221592,0.00002649732,0.01973314,0.0001283771],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947957,0.0001147503,0.000002040935,0.0006133055,0.00009080525,0.002689559,0.00002811421,0.00001230576,0.001653373],"genre_scores_gemma":[0.9972106,0.00001027315,0.0001304602,0.00145321,0.00007895221,0.0003351389,0.000246759,0.00002592919,0.0005086699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01910149,"threshold_uncertainty_score":0.4102381,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01880120690716842,"score_gpt":0.2718837726999043,"score_spread":0.2530825657927359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}